Meru Biotechnologies

About:

Meru Biotechnologies develops a compensated backscattering interferometry solution for understanding and measuring molecular binding.

Website: https://www.merubio.com/

Description:

Meru Biotechnologies develops a compensated backscattering interferometry solution for understanding and measuring molecular binding. The Compensated Back Scattering Interferometry (CBSI) is a label-free and free solution assay technology for measuring molecular interaction. The study of proteins often involves immobilization, labeling, fractionation, and removal from the native environment depriving them of substances needed to function properly. CBSI quantifies the interaction of molecules in solution without labeling, immobilization, tethering, or special impedance plates. The company was founded in 2019 and is headquartered in Richmond, Virginia.